Craig A. Johnson - 19 Jan 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Johnson
Issuer symbol
HRTX
Transactions as of
19 Jan 2024
Net transactions value
$0
Form type
4
Filing time
19 Jan 2024, 21:03:27 UTC
Previous filing
03 Jan 2024
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +13,948 +27% $0.000000 65,820 19 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +83,685 $0.000000 83,685 19 Jan 2024 Common Stock 83,685 $2.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 19, 2025.
F2 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.